Search Tag: Hologic
2017 12 Jul
Hologic, Inc. has announced that the Company plans to release its financial results for the third quarter of fiscal 2017 on Wednesday, August 2, 2017, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time. Interested participants may listen to the call by dialing 877-780-3379...Read more
2017 03 Jul
Hologic, Inc. has announced that it has notified holders of the 2.00% Convertible Exchange Senior Notes due 2042 (CUSIP No. 436440 AC5) issued March 5, 2012, and Wilmington Trust Company, the trustee, paying agent and conversion agent for the notes, that holders are eligible to convert the notes. This conversion right is subject to the terms of...Read more
2017 29 Jun
New Panther Fusion® Module Expands Molecular Testing Capabilities, Increases Productivity and Flexibility for the Laboratory Hologic, Inc. has obtained a CE mark in Europe for its new Panther Fusion system and Panther Fusion assays for flu and respiratory testing, the Company has announced. The Fusion module system offers laboratories the ability...Read more
2017 21 Jun
Hologic, Inc. has announced that it has obtained FDA clearance to market the Aptima® Herpes Simplex Virus (HSV) 1 & 2 molecular assay on the fully automated Panther® system. The test will be commercially available in the 50 United States, U.S. territories and Puerto Rico. According to the U.S. Centers for Disease Control and Prevention, infections...Read more
2017 16 Jun
SculpSure Now Cleared to Treat Five Areas of the Body Hologic, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted an expanded clearance for Cynosure's non-invasive body contouring product, SculpSure , to treat the back and inner and outer thighs. The SculpSure treatment is already FDA-cleared for treatment of...Read more
2017 08 Jun
--Genius exam improves cancer detection and reduces recall rates for women of all ages and breast types, including the nearly 50 percent of women of breast cancer screening age who have dense breasts-- --Separate, recently published data analysis strongly supports starting breast cancer screening using tomosynthesis beginning at age 40-- Hologic,...Read more
2017 17 May
Hologic, Inc. (Nasdaq: HOLX) has announced that Charles J. Dockendorff has been elected to the Company's Board of Directors, effective immediately. Mr. Dockendorff also was appointed to the Company's Audit and Finance Committee. Mr. Dockendorff, who has more than 25 years of experience in the global healthcare industry, was formerly the Executive...Read more
2017 04 Apr
Hologic, Inc. has announced that the Company plans to release its financial results for the second quarter of fiscal 2017 on Wednesday, May 10, 2017, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time. Interested participants may listen to the call by dialing 888-427-9376...Read more
2017 22 Mar
- Transaction Provides Entry into Large, Fast-Growing Medical Aesthetics Market, Boosts Hologic's Growth Rate - Hologic, Inc. has announced that it has completed the acquisition of Cynosure, Inc., a leader in medical aesthetics systems and technologies, for $66 per share in cash. "We are pleased to complete our acquisition of Cynosure, and look...Read more
2017 18 Feb
HCV viral load test now available alongside HIV-1 assay and women's health menu on the fully automated Panther system Hologic, Inc. has announced that the United States Food and Drug Administration (FDA) has granted PMA approval for the Company's hepatitis C virus (HCV) assay for quantitation of HCV viral load and confirming active HCV infection...Read more
2017 14 Feb
-Expands Hologic's Scientific and Commercial Expertise into Large, Adjacent Medical Device Segment Growing at Double-Digit Rate -Accelerates Hologic's Top- and Bottom-Line Growth Rates and is Immediately Accretive to Non-GAAP Earnings per Share \ Hologic, Inc., a leader in women's health, and Cynosure, Inc. (Nasdaq: CYNO), a leader in medical...Read more
2017 13 Feb
Hologic, Inc. has announced that the Company will present at these upcoming investor conferences: The LEERINK Partners 6th Annual Global Healthcare Conference in New York, NY on Wednesday, February 15 at 3:30 pm Eastern Time (ET). The Raymond James 38th Annual Institutional Investor Conference in Orlando, FL on Monday, March 6 at Read more
2017 03 Feb
--Smaller 6 mm Diameter and Product Updates Are Designed to Enhance Patient Comfort and Improve Physician Ease-of-Use-- Hologic, Inc. has announced the launch of its next-generation NovaSure® ADVANCED global endometrial ablation (GEA) system in the United States . The system has been FDA approved. The NovaSure system is designed to reduce...Read more
2017 02 Feb
- Strengthens Efforts to Build a Sustainable Growth Company - - Accelerates Top- and Bottom-Line Growth Rates, Increases Financial Flexibility - Hologic, Inc. has completed the divestiture of its blood screening business to long-time commercial partner, Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS) for a purchase price of $1.85 billion in cash,...Read more
2017 09 Jan
Hologic, Inc. (Nasdaq: HOLX) has announced that Jan Verstreken has been named Regional President for Europe , Middle East and Africa (EMEA) and Canada . Mr. Verstreken's appointment completes Hologic's international sales leadership team, which includes Sanjay Prabhakaran , Regional President for Asia Pacific , and Fernando Davico , General...Read more
2017 08 Jan
Hologic, Inc. has announced that the Company plans to release its financial results for the first quarter of fiscal 2017 on Wednesday, February 1, 2017, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time . Interested participants may listen to the call by dialing...Read more
2017 03 Jan
--High-performing HIV viral load test now available alongside broad women's health menu on the fully automated Panther® system-- Hologic, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted PMA approval for the Company's HIV-1 viral load monitoring assay. The Aptima® HIV-1 Quant assay is a nucleic acid amplification...Read more
2016 21 Dec
Hologic, Inc. announced that the Company will present at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco on January 10, 2017 at 10:30 a.m. Pacific Time. The presentation will be webcast live and may be accessed through a link on the investors section of Hologic's website at http://investors.hologic.com . The webcast will be...Read more
2016 16 Dec
Hologic, Inc. (Nasdaq: HOLX) announced that Amy Wendell has been elected to the Company's Board of Directors, effective December 14. Ms. Wendell also was appointed to the Company's Audit and Finance Committee. Ms. Wendell brings to Hologic a wealth of experience in the healthcare industry, particularly in the areas of market and technology development. ...Read more
2016 15 Dec
- Transaction Strengthens Hologic's Efforts to Build a Sustainable Growth Company - - Deal Accelerates Company's Top- and Bottom-Line Growth Rates, Increases Financial Flexibility - Hologic, Inc. has entered into a definitive agreement to sell its share of its blood screening business to long-time commercial partner, Grifols (MCE: GRF, MCE: GRF.P...Read more
2016 27 Nov
--New products spotlight Hologic's leading tomosynthesis technology, including the world's first dedicated prone biopsy system with 2D or 3D™ imaging-- Hologic, Inc. will highlight its portfolio of innovative, award-winning breast cancer screening and interventional products, including the new Affirm™ prone breast biopsy system, at the 102nd Scientific...Read more
2016 10 Nov
Hologic, Inc. has announced that holders of the 2.00% Convertible Exchange Senior Notes due 2037 (CUSIP No. 436440 AB7) issued November 23, 2010 have the right to surrender their notes for repurchase by the Company. This right is pursuant to the put option under the base indenture governing the notes dated December 10, 2007 , as supplemented by...Read more
2016 08 Nov
Hologic, Inc. announced today that the Company will present at three upcoming investor conferences: The Stifel 2016 Healthcare Conference in New York on Wednesday, November 16 at 2:15 p.m. Eastern Time (ET). The Canaccord Genuity Medical Technologies and Diagnostics Forum 2016 in New York on Thursday, November 17 at 1 p.m. ET . ThRead more
2016 06 Nov
Breast tomosynthesis exams, Hologic calls the exams 3D MAMMOGRAPHY, have shown to be an advance over digital mammography, with higher cancer detection rates and fewer patient recalls for additional testing The new Affirm prone system, which was installed for the first time in Europe earlier this year, is widely considered one the most significant...Read more
2016 03 Nov
- GAAP Diluted EPS of $0.33 Increases 266.7%, Non-GAAP Diluted EPS of $0.52 Increases 20.9% - - Revenue of $726.8 Million Grows 3.4%, 3.8% in Constant Currency - - In Fiscal 2017, Company Expects Mid-Single-Digit Revenue Growth, EPS Growth Roughly Double this Rate - Hologic, Inc. has announced the Company's financial results for the fiscal fourth...Read more
2016 04 Oct
Hologic, Inc. announced today that the Company plans to release its financial results for the fourth quarter of fiscal 2016 on Wednesday, November 2, 2016 , after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time . Interested participants may listen to the call...Read more
2016 04 Oct
Hologic, Inc. has announced that it has notified holders of the 2.00% Convertible Exchange Senior Notes due 2037 (CUSIP No. 436440 AB7) issued November 23, 2010 , and Wilmington Trust Company, the trustee, paying agent and conversion agent for the notes, that holders are eligible to convert the notes. This conversion right is subject to the terms...Read more
2016 30 Sep
Hologic, Inc. has announced that breast cancer survivor and Grammy Award-winner Sheryl Crow will join Steve MacMillan, the Company's Chairman, President and Chief Executive Officer, to ring the Nasdaq Opening Bell on October 3, in conjunction with the start of Breast Cancer Awareness Month. Hologic's participation in the bell ringing marks...Read more
2016 24 Aug
New policy provides coverage of a more accurate mammogram, the Genius™ 3D MAMMOGRAPHY™ exam, for 12.5 million members nationwide Hologic Inc. applauds Cigna's decision to cover breast tomosynthesis for routine breast cancer screening. 1 Effective immediately, this new policy provides Cigna subscribers insurance coverage for Hologic's Genius™...Read more
2016 03 Aug
Hologic, Inc. has announced that the Company will present at two upcoming investor conferences: The Canaccord Genuity Growth Conference 2016 in Boston on Thursday, August 11 at 9:30 am Eastern Time (ET). The Morgan Stanley Global Healthcare Conference in New York on Tuesday, September 13 at 12:20 pm ET. Each presentation will be webcast live Read more